ArticleDrug design, development and therapy2020

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.

Jiaxuan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.